Fund Strategy

EMBL Ventures is an independent venture capital investor that engages in the financing and development of first-in-class products and technologies in the healthcare sector. Based on a strong scientific pedigree, the Fund strategy combines the core competencies of "Pharma" and "Biotech" to arrive at a scalable investment model that seeks at creating commercial value.

"Stefan Herr was instrumental not only throughout the creation and founding of Cenix, from the very first conceptual discussions to the launch of the new legal corporate entity back in 1999, but importantly also in the conclusion of both of our subsequent VC investment rounds. The path of a first-time Biotech entrepreneur is a very challenging one for anyone to take, but would have been literally impossible for me without Stefan's support, guidance and mentoring as the company's business co-founder. This served me well, as I continue learning every day, now, in the 10th year of Cenix."

Chris Echeverri, Ph.D.; CEO/CSO, lead scientific founder of Cenix BioScience, Dresden